Iwasaki S[au] - Search Results

Year	Number of Results
1952	2
1953	1
1957	1
1961	1
1962	3
1963	3
1964	3
1965	3
1966	5
1967	5
1968	4
1969	6
1970	1
1971	5
1972	1
1973	2
1974	1
1976	4
1977	1
1978	3
1979	1
1980	8
1981	2
1982	3
1983	11
1984	8
1985	19
1986	14
1987	16
1988	10
1989	28
1990	24
1991	22
1992	23
1993	28
1994	32
1995	37
1996	32
1997	29
1998	20
1999	15
2000	19
2001	20
2002	20
2003	21
2004	34
2005	40
2006	36
2007	40
2008	49
2009	38
2010	29
2011	39
2012	32
2013	45
2014	38
2015	46
2016	38
2017	46
2018	32
2019	41
2020	51
2021	74
2022	51

1

Selectivity of mRNA degradation by autophagy in yeast.

Makino S, Kawamata T, Iwasaki S, Ohsumi Y. Makino S, et al. Among authors: iwasaki s. Nat Commun. 2021 Apr 19;12(1):2316. doi: 10.1038/s41467-021-22574-6. Nat Commun. 2021. PMID: 33875662 Free PMC article.

2

SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction.

Taki K, Yokota I, Fukumoto T, Iwasaki S, Fujisawa S, Takahashi M, Negishi S, Hayasaka K, Sato K, Oguri S, Nishida M, Sugita J, Konno S, Saito T, Teshima T. Taki K, et al. Among authors: iwasaki s. J Infect Chemother. 2021 Feb;27(2):410-412. doi: 10.1016/j.jiac.2020.10.029. Epub 2020 Oct 31. J Infect Chemother. 2021. PMID: 33214073 Free PMC article.

3

Cap-specific terminal N ⁶-methylation of RNA by an RNA polymerase II-associated methyltransferase.

Akichika S, Hirano S, Shichino Y, Suzuki T, Nishimasu H, Ishitani R, Sugita A, Hirose Y, Iwasaki S, Nureki O, Suzuki T. Akichika S, et al. Among authors: iwasaki s. Science. 2019 Jan 11;363(6423):eaav0080. doi: 10.1126/science.aav0080. Epub 2018 Nov 22. Science. 2019. PMID: 30467178

4

The Translation Inhibitor Rocaglamide Targets a Bimolecular Cavity between eIF4A and Polypurine RNA.

Iwasaki S, Iwasaki W, Takahashi M, Sakamoto A, Watanabe C, Shichino Y, Floor SN, Fujiwara K, Mito M, Dodo K, Sodeoka M, Imataka H, Honma T, Fukuzawa K, Ito T, Ingolia NT. Iwasaki S, et al. Mol Cell. 2019 Feb 21;73(4):738-748.e9. doi: 10.1016/j.molcel.2018.11.026. Epub 2018 Dec 27. Mol Cell. 2019. PMID: 30595437 Free PMC article.

5

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.

Katayama R, Gong B, Togashi N, Miyamoto M, Kiga M, Iwasaki S, Kamai Y, Tominaga Y, Takeda Y, Kagoshima Y, Shimizu Y, Seto Y, Oh-Hara T, Koike S, Nakao N, Hanzawa H, Watanabe K, Yoda S, Yanagitani N, Hata AN, Shaw AT, Nishio M, Fujita N, Isoyama T. Katayama R, et al. Among authors: iwasaki s. Nat Commun. 2019 Aug 9;10(1):3604. doi: 10.1038/s41467-019-11496-z. Nat Commun. 2019. PMID: 31399568 Free PMC article.

6

Mass Screening of Asymptomatic Persons for Severe Acute Respiratory Syndrome Coronavirus 2 Using Saliva.

Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T. Yokota I, et al. Among authors: iwasaki s. Clin Infect Dis. 2021 Aug 2;73(3):e559-e565. doi: 10.1093/cid/ciaa1388. Clin Infect Dis. 2021. PMID: 32976596 Free PMC article.

7

Proximity RNA Labeling by APEX-Seq Reveals the Organization of Translation Initiation Complexes and Repressive RNA Granules.

Padrón A, Iwasaki S, Ingolia NT. Padrón A, et al. Among authors: iwasaki s. Mol Cell. 2019 Aug 22;75(4):875-887.e5. doi: 10.1016/j.molcel.2019.07.030. Mol Cell. 2019. PMID: 31442426 Free PMC article.

8

Diagnostic and therapeutic strategies for Meniere's disease of the Japan Society for Equilibrium Research.

Iwasaki S, Shojaku H, Murofushi T, Seo T, Kitahara T, Origasa H, Watanabe Y, Suzuki M, Takeda N; Committee for Clinical Practice Guidelines of Japan Society for Equilibrium Research. Iwasaki S, et al. Auris Nasus Larynx. 2021 Feb;48(1):15-22. doi: 10.1016/j.anl.2020.10.009. Epub 2020 Oct 29. Auris Nasus Larynx. 2021. PMID: 33131962 Review.

9

Comparative morphology of the primate tongue.

Iwasaki SI, Yoshimura K, Shindo J, Kageyama I. Iwasaki SI, et al. Ann Anat. 2019 May;223:19-31. doi: 10.1016/j.aanat.2019.01.008. Epub 2019 Feb 6. Ann Anat. 2019. PMID: 30738175 Review.

10

Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis.

Chuma M, Uojima H, Hattori N, Arase Y, Fukushima T, Hirose S, Kobayashi S, Ueno M, Tezuka S, Iwasaki S, Wada N, Kubota K, Tsuruya K, Shimma Y, Hiroki I, Takuya E, Tokoro C, Iwase S, Miura Y, Moriya S, Watanabe T, Hidaka H, Morimoto M, Numata K, Kusano C, Kagawa T, Maeda S. Chuma M, et al. Among authors: iwasaki s. Hepatol Res. 2022 Mar;52(3):269-280. doi: 10.1111/hepr.13732. Epub 2021 Nov 30. Hepatol Res. 2022. PMID: 34761470

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results